Global Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction Market Growth (Status and Outlook) 2026-2032

The global Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction market size is predicted to grow from US$ 6113 million in 2025 to US$ 13011 million in 2032; it is expected to grow at a CAGR of 11.7% from 2026 to 2032.

Strain engineering and the construction of cellular factories serve as the very source and cornerstone of the entire biomanufacturing process; their objective is to create microbial strains or cell lines capable of efficiently synthesizing target products. This phase is primarily conducted within a laboratory setting, and its operational workflow relies heavily on molecular biology and gene editing technologies. Once a high-performance strain has been obtained, the subsequent step is not to immediately scale up to mass production, but rather—at the laboratory scale—to "tailor-make" an optimal growth and production environment specifically for that strain. The goal of this stage is to explore and identify the critical process parameters that influence both product yield and quality.

United States market for Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction players cover Bio-Rad, Thermo Fisher, Eppendorf, Roche, QIAGEN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction Industry Forecast” looks at past sales and reviews total world Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction sales in 2025, providing a comprehensive analysis by region and market sector of projected Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction sales for 2026 through 2032. With Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction industry.

This Insight Report provides a comprehensive analysis of the global Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction.

This report presents a comprehensive overview, market shares, and growth opportunities of Biomanufacturing Equipment for the Stages of Microbial Strain Engineering and Cell Factory Construction market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cell Engineering
Microbial Strain Engineering

Segmentation by Equipment Capacity:
1-50 L
50-200 L
200-500 L
＞500 L

Segmentation by Equipment:
Production and Cultivation Equipment
Clarification and Primary Separation Equipment
Downstream Purification and Refinement Equipment
Plant Engineering Support Systems
Others

Segmentation by Application:
Biopharmaceuticals
Food and Nutrition
Bio-agriculture
Consumer and Personal Care
Bioenergy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Thermo Fisher
Eppendorf
Roche
QIAGEN
DeNovix
GEA
TRUKING TECHNOLOGY LIMITED
Tofflon Science and Technology Group
Orient Gene
Shanghai Triowin Intelligent Machinery
ABEC
Krones AG
Solaris Biotech
DCI, Inc.
Holloway America
Cotter Brothers Corporation
Actini Group
Pierre Guerin
BIIC Bianchi SpA
Flottweg SE
Tomoe
Austar Lifesciences Limited
Jiangsu Hanbon Science and Technology
Lisure Science(Suzhou)Co
Danaher Corporation
Sartorius
Beijing Tong Heng Innovation Technology Co
YMC CO., LTD.
Morimatsu Industry
Sulzer Ltd
Sinomach General Machinery Science and Technology
Jiangsu Liangyou Zhengda
Jiangsu Zhengchang Group
Bühler AG
Andritz AG
TECNIC
Ohkawara Kakohki Co., Ltd.
Buss-SMS-Canzler GmbH

Please note: The report will take approximately 2 business days to prepare and deliver. Show more